A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar Degeneration
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Memantine (Primary)
- Indications Cerebral atrophy
- Focus Adverse reactions
- 16 Dec 2012 New trial record
Latest Information Update: 07 Nov 2021